Variant report

Variant	esv3392470
Chromosome Location	chr7:150691544-150694892
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:188)
CpG islands
(count:61)
Chromatin interactive
region (count:10)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:188 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr7:150691260-150691987	K562	blood:	n/a	n/a
2	ATF3	chr7:150691481-150692007	K562	blood:	n/a	n/a
3	BHLHE40	chr7:150693763-150694256	K562	blood:	n/a	n/a
4	BHLHE40	chr7:150692426-150692566	K562	blood:	n/a	n/a
5	BHLHE40	chr7:150691643-150692073	K562	blood:	n/a	chr7:150691714-150691730 chr7:150691814-150691830
6	CBX3	chr7:150691613-150691984	K562	blood:	n/a	n/a
7	CBX3	chr7:150691033-150692292	K562	blood:	n/a	n/a
8	CBX3	chr7:150693426-150694645	K562	blood:	n/a	n/a
9	CCNT2	chr7:150691592-150692064	K562	blood:	n/a	chr7:150691826-150691846
10	CCNT2	chr7:150694301-150694612	K562	blood:	n/a	n/a
11	CCNT2	chr7:150693807-150694012	K562	blood:	n/a	n/a
12	CEBPB	chr7:150693819-150694049	K562	blood:	n/a	n/a
13	CEBPD	chr7:150691553-150692108	K562	blood:	n/a	n/a
14	CHD2	chr7:150694346-150694409	K562	blood:	n/a	n/a
15	CHD2	chr7:150691631-150692052	K562	blood:	n/a	n/a
16	CHD2	chr7:150691677-150691696	GM12878	blood:	n/a	n/a
17	CTCF	chr7:150693800-150693950	NB4	blood:	n/a	n/a
18	CTCF	chr7:150693697-150694160	K562	blood:	n/a	n/a
19	CTCF	chr7:150693930-150693931	K562	blood:	n/a	n/a
20	CTCF	chr7:150691590-150691854	K562	blood:	n/a	chr7:150691814-150691823
21	CUX1	chr7:150691438-150691967	K562	blood:	n/a	n/a
22	E2F6	chr7:150691623-150692009	K562	blood:	n/a	n/a
23	E2F6	chr7:150692095-150692273	K562	blood:	n/a	n/a
24	E2F6	chr7:150693670-150694111	K562	blood:	n/a	chr7:150694091-150694101 chr7:150693751-150693763
25	E2F6	chr7:150691551-150692140	K562	blood:	n/a	n/a
26	E2F6	chr7:150691476-150691958	K562	blood:	n/a	n/a
27	EGR1	chr7:150693681-150694084	K562	blood:	n/a	chr7:150694065-150694075
28	EGR1	chr7:150693793-150694555	K562	blood:	n/a	chr7:150694414-150694421 chr7:150694065-150694075
29	EGR1	chr7:150694123-150694562	K562	blood:	n/a	chr7:150694414-150694421
30	EGR1	chr7:150691489-150691957	K562	blood:	n/a	chr7:150691829-150691838 chr7:150691590-150691603
31	EGR1	chr7:150691575-150691996	K562	blood:	n/a	chr7:150691829-150691838 chr7:150691590-150691603
32	ELF1	chr7:150691541-150692168	K562	blood:	n/a	n/a
33	ELF1	chr7:150694091-150694474	K562	blood:	n/a	n/a
34	ELF1	chr7:150691585-150692075	K562	blood:	n/a	n/a
35	ELF1	chr7:150693385-150694139	K562	blood:	n/a	n/a
36	ELF1	chr7:150693413-150694079	K562	blood:	n/a	n/a
37	ELK1	chr7:150691529-150692016	K562	blood:	n/a	n/a
38	ELK1	chr7:150694168-150694169	K562	blood:	n/a	n/a
39	EP300	chr7:150694256-150694399	K562	blood:	n/a	n/a
40	EP300	chr7:150693639-150693992	K562	blood:	n/a	chr7:150693812-150693821
41	EP300	chr7:150691525-150692096	K562	blood:	n/a	n/a
42	EP300	chr7:150691642-150691945	K562	blood:	n/a	n/a
43	ETS1	chr7:150691469-150692136	K562	blood:	n/a	chr7:150691830-150691837 chr7:150691828-150691841 chr7:150691830-150691841 chr7:150691829-150691843
44	ETS1	chr7:150691557-150692021	K562	blood:	n/a	chr7:150691830-150691837 chr7:150691828-150691841 chr7:150691830-150691841 chr7:150691829-150691843
45	FOSL1	chr7:150691502-150692060	K562	blood:	n/a	chr7:150691888-150691896
46	FOXP2	chr7:150693679-150693999	PFSK-1	brain:	n/a	n/a
47	GABPA	chr7:150691420-150692502	K562	blood:	n/a	n/a
48	GABPA	chr7:150691587-150692109	K562	blood:	n/a	n/a
49	GABPA	chr7:150693469-150694506	K562	blood:	n/a	n/a
50	GATA1	chr7:150691523-150692163	PBDE	blood:	n/a	chr7:150691800-150691810 chr7:150691826-150691843 chr7:150691829-150691839 chr7:150691837-150691847

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr7:150694028-150694078	HRPEpiC	eye:	n/a
2	chr7:150694028-150694078	PrEC	prostate:	n/a
3	chr7:150694028-150694078	U87	brain:	n/a
4	chr7:150694028-150694078	PFSK-1	brain:	n/a
5	chr7:150694028-150694078	HepG2	liver:	n/a
6	chr7:150694028-150694078	AG09319	gingival:	n/a
7	chr7:150694028-150694078	H1-hESC	embryonic stem cell:	embryo
8	chr7:150694028-150694078	AG10803	skin:	n/a
9	chr7:150694028-150694078	ovcar-3	ovarian:	n/a
10	chr7:150694028-150694078	HUVEC	blood vessel:	n/a
11	chr7:150694028-150694078	SK-N-MC	brain:	n/a
12	chr7:150694028-150694078	AG04450	lung:	fetal
13	chr7:150694028-150694078	BE2_C	brain:	n/a
14	chr7:150694028-150694078	MCF10A-Er-Src	breast:	n/a
15	chr7:150694028-150694078	CMK	blood:	n/a
16	chr7:150694028-150694078	HEEpiC	esophagus:	n/a
17	chr7:150694028-150694078	MCF-7	breast:	n/a
18	chr7:150694028-150694078	GM12891	blood:	n/a
19	chr7:150694028-150694078	HRCEpiC	kidney:	n/a
20	chr7:150694028-150694078	Caco-2	colon:	n/a
21	chr7:150694028-150694078	NB4	blood:	n/a
22	chr7:150694028-150694078	HIPEpiC	eye:	n/a
23	chr7:150694028-150694078	NHDF-neo	bronchial:	n/a
24	chr7:150694028-150694078	T-47D	breast:	n/a
25	chr7:150694028-150694078	AG04449	skin:	fetal
26	chr7:150694028-150694078	HAEpiC	amniotic membrane:	n/a
27	chr7:150694028-150694078	HMEC	breast:	n/a
28	chr7:150694028-150694078	K562	blood:	n/a
29	chr7:150694028-150694078	HCPEpiC	choroid plexus:	n/a
30	chr7:150694028-150694078	GM06990	blood:	n/a
31	chr7:150694028-150694078	NT2-D1	testis:	n/a
32	chr7:150694028-150694078	HL-60	blood:	n/a
33	chr7:150694028-150694078	SAEC	small airway:	n/a
34	chr7:150694028-150694078	HPAEpiC	pulmonary alveolar:	n/a
35	chr7:150694028-150694078	HCM	heart:	n/a
36	chr7:150694028-150694078	GM19239	blood:	n/a
37	chr7:150694028-150694078	HNPCEpiC	eye:	n/a
38	chr7:150694028-150694078	BJ	skin:	n/a
39	chr7:150694028-150694078	HRE	kidney:	n/a
40	chr7:150694028-150694078	HCF	heart:	n/a
41	chr7:150694028-150694078	GM12892	blood:	n/a
42	chr7:150694028-150694078	Hela-S3	cervix:	n/a
43	chr7:150694028-150694078	HEK293	kidney:	embryo
44	chr7:150694028-150694078	GM12878	blood:	n/a
45	chr7:150694028-150694078	SKMC	muscle:	n/a
46	chr7:150694028-150694078	SK-N-SH	brain:	n/a
47	chr7:150694028-150694078	ProgFib	skin:	n/a
48	chr7:150694028-150694078	SK-N-SH_RA	brain:	n/a
49	chr7:150694028-150694078	Hepatocyte	liver:	n/a
50	chr7:150694028-150694078	LNCaP	prostate:	n/a

(count:10 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr7:150690495..150692157-chr7:150930437..150932550,2	K562	blood:
2	chr7:150671828..150674694-chr7:150692153..150695076,2	MCF-7	breast:
3	chr7:150694261..150697660-chr7:150712751..150716037,3	MCF-7	breast:
4	chr7:150595209..150595856-chr7:150691392..150692242,2	K562	blood:
5	chr7:150688771..150691560-chr7:150756219..150758072,2	MCF-7	breast:
6	chr7:150689613..150692426-chr7:150754513..150757333,2	MCF-7	breast:
7	chr7:150690578..150692213-chr7:150720359..150721973,2	MCF-7	breast:
8	chr7:150691223..150692147-chr7:150705540..150706494,2	K562	blood:
9	chr7:150692809..150694996-chr7:150810085..150812572,2	MCF-7	breast:
10	chr7:150694065..150696658-chr7:150697415..150699759,2	MCF-7	breast:

No data

Variant related genes	Relation type
NOS3	TF binding region
NOS3	CpG island
ENSG00000164867	chromatin interactions
ENSG00000133612	chromatin interactions
ENSG00000033100	chromatin interactions
ENSG00000164889	chromatin interactions
ENSG00000181652	chromatin interactions
ENSG00000164885	chromatin interactions

Extended variants
information (count: 182 )
Associated
traits (count: 88 )

Variant overlapped rSNPs/rCNVs (count:182 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs368890060	chr7:150691580-150691581	Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
2	rs71539867	chr7:150691602-150691603	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
3	rs549278901	chr7:150691605-150691606	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
4	rs73167644	chr7:150691622-150691623	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
5	rs565994416	chr7:150691631-150691632	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
6	rs184888624	chr7:150691635-150691636	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
7	rs543273416	chr7:150691659-150691660	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
8	rs201372329	chr7:150691677-150691678	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
9	rs577613145	chr7:150691689-150691690	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
10	rs189488945	chr7:150691780-150691781	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
11	rs565074142	chr7:150691819-150691820	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
12	rs536736279	chr7:150691850-150691851	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
13	rs556670102	chr7:150691867-150691868	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
14	rs576205749	chr7:150691895-150691896	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
15	rs117197062	chr7:150691898-150691899	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
16	rs529761757	chr7:150691899-150691900	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
17	rs562012448	chr7:150691994-150691995	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
18	rs572661791	chr7:150692007-150692008	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
19	rs541372140	chr7:150692015-150692016	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
20	rs564322888	chr7:150692020-150692021	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
21	rs533403978	chr7:150692040-150692041	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
22	rs371420556	chr7:150692044-150692045	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
23	rs563801577	chr7:150692049-150692050	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
24	rs56066755	chr7:150692095-150692096	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs145601974	chr7:150692110-150692111	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
26	rs114531422	chr7:150692125-150692126	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
27	rs41394247	chr7:150692137-150692138	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs551694432	chr7:150692142-150692143	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
29	rs571138341	chr7:150692178-150692179	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
30	rs114144563	chr7:150692186-150692187	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs556610062	chr7:150692199-150692200	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs567038918	chr7:150692223-150692224	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs201405443	chr7:150692293-150692294	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs374957936	chr7:150692296-150692297	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs367984752	chr7:150692306-150692307	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs551113047	chr7:150692320-150692321	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs200364898	chr7:150692333-150692334	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs147733456	chr7:150692363-150692364	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs555547256	chr7:150692372-150692373	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs572649815	chr7:150692387-150692388	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs541352173	chr7:150692393-150692394	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs375304782	chr7:150692398-150692399	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs181242083	chr7:150692411-150692412	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs200007787	chr7:150692412-150692413	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs201881217	chr7:150692415-150692416	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs201144173	chr7:150692430-150692431	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
47	rs1800781	chr7:150692444-150692445	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs112325989	chr7:150692445-150692446	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
49	rs371126685	chr7:150692450-150692451	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
50	rs376311433	chr7:150692454-150692455	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:88)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Seminomas	18059402	CNVD
Testicular cancer	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
T-cell lymphomas	19863542	CNVD
Malaria	21533027	CNVD
Melanoma	18172304	CNVD
Renal cell carcinoma	19461508	CNVD
head and neck squamous cell carcinoma	19289630	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Wilms tumour	21544195	CNVD
Squamous cell cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	17387387	CNVD
Low-grade fibromyxoid sarcoma	0	CNVD
Oligodendroglial tumors	17285580	CNVD
Endometrial cancer	22040021	CNVD
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	21264507	CNVD
Shwachman-Diamond syndrome	22934832	CNVD
Colorectal cancer	19359472	CNVD
Cutaneous malignant melanoma	17690212	CNVD
Leukemia	17361228	CNVD
Breast cancer	16461572	CNVD
Peripheral t-cell lymphoma	19118030	CNVD
Malignant melanoma	17690212	CNVD
Renal cell carcinoma	18592004	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Multiple myeloma	17550852	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Neurodevelopmental disorder	22521361	CNVD
abortions and stillbirths	19751515	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute myeloid leukemia	20729466	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Burkitt''s lymphoma	19759907	CNVD
lymphocytic leukemia	21291569	CNVD
Acute myeloid leukemia	21251322	CNVD
Prostate cancer	16573809	CNVD
Medulloblastoma	16783165	CNVD
abnormal development	18461090	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Papillary thyroid carcinoma	21436994	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Hodgkin''s lymphoma	18179710	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Breast cancer	17603634	CNVD
Urothelial carcinoma	18382360	CNVD
Myelodysplastic syndrome	17634407	CNVD
Multiple myeloma	16461302	CNVD
Neuroblastoma	18923191	CNVD
Schizophrenia	17646849	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Acute myeloid leukemia	16864856	CNVD
Autism	20808228	CNVD
Breast cancer	21509527	CNVD
Ovarian cancer	21720365	CNVD
Heart disease	21282601	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	21045282	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Glioblastoma multiforme	17002787	CNVD
Lobular carcinoma	20920651	CNVD
Long-qt syndrome	20920651	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Liver carcinoma	19366792	CNVD
Long-qt syndrome	17576883	CNVD
Bradycardia syndrome	17576883	CNVD
Sudden cardiac death	19188705	CNVD
renal disease	17924346	CNVD
Ovarian cancer	21781307	CNVD
Adrenocortical carcinoma	18281524	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Melanoma	20877625	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:264 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:150686200-150698000	Weak transcription	H9 Cell Line	embryonic stem cell
2	chr7:150688800-150697200	Weak transcription	Pancreas	Pancrea
3	chr7:150689600-150692200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
4	chr7:150689800-150691600	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
5	chr7:150689800-150692600	Enhancers	H1 Cell Line	embryonic stem cell
6	chr7:150689800-150692600	Flanking Active TSS	Placenta	Placenta
7	chr7:150690000-150691600	Enhancers	Primary T helper cells fromperipheralblood	blood
8	chr7:150690000-150692600	Enhancers	Fetal Heart	heart
9	chr7:150690000-150692800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
10	chr7:150690200-150691600	Enhancers	Primary T killer memory cells from peripheral blood	blood
11	chr7:150690200-150691800	Enhancers	Primary T cells from cord blood	blood
12	chr7:150690200-150692200	Enhancers	ES-I3 Cell Line	embryonic stem cell
13	chr7:150690200-150692400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
14	chr7:150690200-150692600	Enhancers	HUES6 Cell Line	embryonic stem cell
15	chr7:150690400-150692400	Active TSS	Stomach Smooth Muscle	stomach
16	chr7:150690400-150692600	Enhancers	Primary hematopoietic stem cells	blood
17	chr7:150690400-150692800	Enhancers	Fetal Lung	lung
18	chr7:150690600-150691600	Enhancers	Primary T helper naive cells fromperipheralblood	blood
19	chr7:150690800-150691600	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
20	chr7:150690800-150691600	Active TSS	Left Ventricle	heart
21	chr7:150690800-150691600	Active TSS	Spleen	Spleen
22	chr7:150690800-150691800	Enhancers	Primary T helper cells PMA-I stimulated	--
23	chr7:150690800-150692000	Flanking Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
24	chr7:150690800-150692000	Enhancers	Primary T regulatory cells fromperipheralblood	blood
25	chr7:150690800-150692200	Enhancers	ES-WA7 Cell Line	embryonic stem cell
26	chr7:150690800-150692400	Active TSS	Duodenum Smooth Muscle	Duodenum
27	chr7:150690800-150692600	Flanking Active TSS	HUVEC	blood vessel
28	chr7:150691000-150691800	Active TSS	Skeletal Muscle Female	skeletal muscle
29	chr7:150691000-150692000	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
30	chr7:150691000-150692000	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
31	chr7:150691000-150692000	Active TSS	Duodenum Mucosa	Duodenum
32	chr7:150691000-150692200	Active TSS	Liver	Liver
33	chr7:150691000-150692200	Flanking Active TSS	Fetal Stomach	stomach
34	chr7:150691000-150692400	Active TSS	Brain Anterior Caudate	brain
35	chr7:150691000-150692400	Active TSS	Psoas Muscle	Psoas
36	chr7:150691000-150692400	Active TSS	Rectal Smooth Muscle	rectum
37	chr7:150691000-150692600	Active TSS	Pancreatic Islets	Pancreatic Islet
38	chr7:150691200-150691600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
39	chr7:150691200-150691600	Weak transcription	Colonic Mucosa	Colon
40	chr7:150691200-150691800	Enhancers	Primary T helper naive cells from peripheral blood	blood
41	chr7:150691200-150692000	Active TSS	Lung	lung
42	chr7:150691200-150692000	Active TSS	Skeletal Muscle Male	skeletal muscle
43	chr7:150691200-150692400	Enhancers	Primary T killer naive cells fromperipheralblood	blood
44	chr7:150691200-150692600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
45	chr7:150691200-150692600	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
46	chr7:150691200-150692800	Enhancers	Primary monocytes fromperipheralblood	blood
47	chr7:150691200-150693800	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
48	chr7:150691400-150691600	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
49	chr7:150691400-150691600	Active TSS	Brain Substantia Nigra	brain
50	chr7:150691400-150691600	Active TSS	Fetal Adrenal Gland	Adrenal Gland

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links